Dr. Michael A. Mcculloch, MD
Pediatric Cardiology (Pediatric Cardiology Physician)
At a glance
- Medical school
- University of Texas Medical School at San Antonio (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of Texas Medical School at San Antonio
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Cardiology Physician primary
VA license 0101262131 -
Pediatric Critical Care Medicine Physician
VA license 0101262131
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Virginia Medical Center Charlottesville, VA
Medical groups
- University of Virginia Physicians Group (1,717 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 2 companies reported 5 payments worth $418 in total to this clinician.
| Abbott Laboratories | $279 |
|---|---|
| Bridgebio Pharma, Inc. | $139 |
| Food and Beverage | $211 |
|---|---|
| Travel and Lodging | $207 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Jan 9, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Austin, TX · in-kind | $125 |
| Abbott Laboratories Jan 9, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Austin, TX · in-kind | $72.07 |
| Abbott Laboratories Jan 9, 2025 | Travel and Lodging THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Structural Heart · travel to Austin, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $167,170 in research payments for these studies, mostly to the institutions running them.
- A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obstructive Hypertrophic Cardiomyopathy
E.r. Squibb & Sons, L.l.c. - A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension PAH
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.